Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16.5M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
+231K
-
Total reported value, excl. options
-
$615M
-
Value change
-
-$10.2M
-
Put/Call ratio
-
0
-
Number of buys
-
35
-
Number of sells
-
-53
-
Price
-
$21.99
Significant Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q1 2022
111 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2022.
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3.97M shares), FMR LLC (3.18M shares), PERCEPTIVE ADVISORS LLC (2.8M shares), BlackRock Inc. (1.8M shares), Ponoi Management, LLC (1.6M shares), Column Group LLC (1.4M shares), STATE STREET CORP (1.35M shares), KPCB XV Associates, LLC (1.3M shares), VANGUARD GROUP INC (1.22M shares), and KINGDON CAPITAL MANAGEMENT, L.L.C. (1.09M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.